Pediatric disk disease

Jonathan R Slotkin1, John M K Mislow, Arthur L Day

  • 1Department of Neurosurgery, The Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.

Insights

Pediatric intervertebral disk herniation is rare and challenging to diagnose. This review offers a straightforward strategy for evaluating and treating childhood disk herniation, highlighting key differences from adult cases.

Area of Science:

  • Pediatric Orthopedics
  • Neurosurgery
  • Radiology

Background:

  • Intervertebral disk herniation (IDH) in children is uncommon but can cause significant disability.
  • Diagnosis of pediatric IDH is often delayed due to its rarity and atypical presentations.
  • Understanding the unique aspects of pediatric IDH is crucial for effective management.

Purpose of the Study:

  • To review the fundamental aspects of pediatric intervertebral disk herniation.
  • To present a rational and simplified strategy for the evaluation and treatment of pediatric IDH.
  • To emphasize the distinctions between pediatric and adult disk disease.

Main Methods:

  • Literature review focusing on pediatric intervertebral disk herniation.
  • Analysis of diagnostic challenges and imaging findings in children.
  • Comparison of treatment modalities for pediatric versus adult disk herniation.

Main Results:

  • Pediatric IDH presents differently than in adults, often with subtle or non-specific symptoms.
  • Diagnostic delays are common, impacting treatment outcomes.
  • Treatment strategies must consider the unique anatomy and growth potential of pediatric patients.

Conclusions:

  • A systematic approach is needed for diagnosing and managing pediatric intervertebral disk herniation.
  • Recognizing the differences from adult disk disease is essential for optimal patient care.
  • Further research into pediatric-specific treatment protocols is warranted.

Related Concept Videos

Degenerative Disc Disease ll: Pathophysiology01:23

Degenerative Disc Disease ll: Pathophysiology

The symptoms of degenerative disc disease arise from a combination of mechanical compression, vascular compromise, and biochemical inflammation, which together disrupt nerve function and produce pain.Mechanical CompressionDisc degeneration reduces height and elasticity, predisposing to herniation of the nucleus pulposus, a major cause of radicular pain. Herniations may be protrusion (bulging with intact annulus), extrusion (nucleus extends beyond disc but remains connected), or sequestration...
Degenerative Disc Disease I: Introduction01:27

Degenerative Disc Disease I: Introduction

Degenerative disc disease is a chronic condition in which intervertebral discs gradually lose structure and function. It is not infectious or autoimmune; rather, it results from age-related biochemical and mechanical changes, influenced by genetic, metabolic, and environmental factors.Structure and Function of DiscsThe spine contains 23 intervertebral discs that absorb load, distribute forces, maintain spacing, and allow flexibility. Each disc consists of a nucleus pulposus, a gel-like core...
Herniated Intervertebral Disc l: Introduction01:29

Herniated Intervertebral Disc l: Introduction

Intervertebral disc herniation refers to the displacement of the nucleus pulposus (the gel-like inner core of the disc) through a tear or weakened area in the annulus fibrosus (the outer fibrous ring). The displaced disc material extends beyond the normal boundaries of the disc space and may compress or irritate nearby spinal nerve roots or, less commonly, the spinal cord.Etiology and Risk FactorsHerniation commonly results from degeneration, in which aging reduces disc hydration and...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...